Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG.
Olivieri A, Santini G, Patti C, Chisesi T, De Souza C, Rubagotti A, Aversa S, Billio A, Porcellini A, Candela M, Centurioni R, Congiu AM, Brunori M, Nati S, Spriano M, Vimercati R, Marino G, Contu A, Tedeschi L, Majolino I, Crugnola M, Sertoli MR; NHLCSG.
Olivieri A, et al. Among authors: centurioni r.
Ann Oncol. 2005 Dec;16(12):1941-8. doi: 10.1093/annonc/mdi399. Epub 2005 Sep 12.
Ann Oncol. 2005.
PMID: 16157621
Free article.
Clinical Trial.